Concepts (292)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Smooth | 52 | 2014 | 358 | 3.370 |
Why?
|
| Trachea | 46 | 2014 | 293 | 2.390 |
Why?
|
| Muscle Contraction | 36 | 2014 | 294 | 1.640 |
Why?
|
| Acetylcholine | 21 | 2008 | 181 | 1.100 |
Why?
|
| Bronchi | 8 | 2004 | 234 | 0.610 |
Why?
|
| Depsipeptides | 3 | 2010 | 32 | 0.510 |
Why?
|
| In Vitro Techniques | 28 | 2004 | 1010 | 0.480 |
Why?
|
| Thiazoles | 3 | 2008 | 130 | 0.480 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 3 | 2008 | 103 | 0.480 |
Why?
|
| Dogs | 28 | 2014 | 719 | 0.450 |
Why?
|
| Immunization | 4 | 1994 | 165 | 0.380 |
Why?
|
| Thiazolidines | 3 | 2008 | 18 | 0.350 |
Why?
|
| Myosins | 6 | 2008 | 94 | 0.320 |
Why?
|
| Electric Stimulation | 14 | 2003 | 397 | 0.310 |
Why?
|
| Receptors, Muscarinic | 4 | 2000 | 48 | 0.300 |
Why?
|
| Isometric Contraction | 7 | 2003 | 41 | 0.290 |
Why?
|
| Bronchoconstriction | 7 | 2012 | 56 | 0.280 |
Why?
|
| Respiratory Hypersensitivity | 5 | 1997 | 41 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2008 | 224 | 0.270 |
Why?
|
| Actin Cytoskeleton | 3 | 2009 | 201 | 0.270 |
Why?
|
| Potassium Chloride | 10 | 2003 | 88 | 0.260 |
Why?
|
| Asthma | 10 | 2009 | 1051 | 0.260 |
Why?
|
| Calcium | 4 | 2000 | 1205 | 0.260 |
Why?
|
| Animals | 56 | 2014 | 28945 | 0.260 |
Why?
|
| Dose-Response Relationship, Drug | 14 | 2008 | 1973 | 0.250 |
Why?
|
| Immunization, Passive | 2 | 1997 | 75 | 0.240 |
Why?
|
| Acetylcholinesterase | 5 | 1992 | 49 | 0.240 |
Why?
|
| Capsaicin | 2 | 1995 | 45 | 0.220 |
Why?
|
| Physostigmine | 6 | 1997 | 20 | 0.220 |
Why?
|
| Bronchial Hyperreactivity | 4 | 2012 | 77 | 0.210 |
Why?
|
| Airway Obstruction | 4 | 2008 | 117 | 0.190 |
Why?
|
| Stress, Mechanical | 7 | 2008 | 261 | 0.190 |
Why?
|
| Serotonin | 7 | 1998 | 219 | 0.180 |
Why?
|
| Indomethacin | 4 | 2012 | 62 | 0.180 |
Why?
|
| Antigens, Helminth | 2 | 1998 | 22 | 0.170 |
Why?
|
| Atropine | 5 | 2000 | 61 | 0.170 |
Why?
|
| Cats | 3 | 1998 | 306 | 0.170 |
Why?
|
| Muscle Tonus | 3 | 1997 | 20 | 0.170 |
Why?
|
| Cholinesterase Inhibitors | 3 | 1997 | 49 | 0.160 |
Why?
|
| Myosin Light Chains | 4 | 2003 | 29 | 0.150 |
Why?
|
| Muscle Relaxation | 2 | 1997 | 18 | 0.150 |
Why?
|
| Guinea Pigs | 5 | 1997 | 172 | 0.140 |
Why?
|
| Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide | 1 | 1997 | 3 | 0.140 |
Why?
|
| Prostaglandin Antagonists | 1 | 1997 | 8 | 0.140 |
Why?
|
| Receptors, Prostaglandin E | 1 | 1997 | 5 | 0.140 |
Why?
|
| Xanthones | 1 | 1997 | 11 | 0.140 |
Why?
|
| Dinoprostone | 1 | 1997 | 74 | 0.130 |
Why?
|
| Muscarinic Agonists | 1 | 1997 | 23 | 0.130 |
Why?
|
| Cyclosporine | 1 | 1998 | 242 | 0.130 |
Why?
|
| Respiratory Muscles | 1 | 1997 | 28 | 0.130 |
Why?
|
| Receptors, Tachykinin | 1 | 1995 | 9 | 0.120 |
Why?
|
| Blotting, Western | 5 | 2014 | 798 | 0.110 |
Why?
|
| Dystrophin | 1 | 2014 | 25 | 0.110 |
Why?
|
| Phosphorylation | 7 | 2010 | 1157 | 0.110 |
Why?
|
| Swine | 9 | 2002 | 618 | 0.110 |
Why?
|
| Histamine | 7 | 1998 | 124 | 0.100 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1993 | 26 | 0.100 |
Why?
|
| Pertussis Toxin | 1 | 1993 | 32 | 0.100 |
Why?
|
| Kinetics | 7 | 2001 | 1562 | 0.100 |
Why?
|
| Lymphatic System | 1 | 1993 | 55 | 0.100 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2012 | 22 | 0.100 |
Why?
|
| Caveolin 1 | 1 | 2012 | 25 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1993 | 73 | 0.100 |
Why?
|
| Methacholine Chloride | 6 | 2014 | 67 | 0.090 |
Why?
|
| Cyclooxygenase 2 | 1 | 2012 | 100 | 0.090 |
Why?
|
| Parasympathetic Nervous System | 2 | 1991 | 36 | 0.090 |
Why?
|
| Lung | 3 | 2014 | 1382 | 0.090 |
Why?
|
| Respiratory System | 3 | 2014 | 121 | 0.090 |
Why?
|
| Male | 21 | 2008 | 45870 | 0.090 |
Why?
|
| Pollen | 2 | 1993 | 87 | 0.080 |
Why?
|
| Epithelium | 3 | 1997 | 326 | 0.080 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2014 | 141 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 98 | 0.080 |
Why?
|
| Ascaris suum | 3 | 1998 | 10 | 0.080 |
Why?
|
| Isotonic Contraction | 1 | 1989 | 2 | 0.080 |
Why?
|
| Isoproterenol | 4 | 1994 | 62 | 0.070 |
Why?
|
| Cells, Cultured | 5 | 2014 | 2943 | 0.070 |
Why?
|
| Hypersensitivity | 2 | 2006 | 166 | 0.070 |
Why?
|
| Blood Proteins | 2 | 2000 | 151 | 0.070 |
Why?
|
| Respiratory Mechanics | 2 | 2007 | 114 | 0.070 |
Why?
|
| Aerosols | 3 | 2008 | 48 | 0.070 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1988 | 16 | 0.070 |
Why?
|
| Ovalbumin | 4 | 1994 | 110 | 0.070 |
Why?
|
| Receptors, Cholinergic | 1 | 1988 | 77 | 0.070 |
Why?
|
| Inflammation | 1 | 1993 | 1068 | 0.070 |
Why?
|
| Steroids | 1 | 2008 | 174 | 0.070 |
Why?
|
| Vasoconstriction | 2 | 2006 | 93 | 0.070 |
Why?
|
| Pirenzepine | 2 | 2000 | 8 | 0.070 |
Why?
|
| Parasympatholytics | 2 | 2000 | 19 | 0.060 |
Why?
|
| Flax | 1 | 2006 | 1 | 0.060 |
Why?
|
| Aging | 6 | 2008 | 766 | 0.060 |
Why?
|
| Pulmonary Ventilation | 1 | 2006 | 33 | 0.060 |
Why?
|
| Environment | 1 | 2008 | 231 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 297 | 0.060 |
Why?
|
| Dietary Supplements | 1 | 2006 | 133 | 0.060 |
Why?
|
| Hypercholesterolemia | 1 | 2006 | 161 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 321 | 0.060 |
Why?
|
| Inflammation Mediators | 2 | 2003 | 163 | 0.060 |
Why?
|
| Osmolar Concentration | 2 | 1995 | 180 | 0.050 |
Why?
|
| Oxazoles | 2 | 2003 | 18 | 0.050 |
Why?
|
| Vasodilator Agents | 2 | 2006 | 151 | 0.050 |
Why?
|
| Myosin Heavy Chains | 3 | 2014 | 91 | 0.050 |
Why?
|
| Bradykinin | 2 | 2000 | 46 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2004 | 229 | 0.050 |
Why?
|
| Serum Response Factor | 1 | 2003 | 46 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2003 | 88 | 0.050 |
Why?
|
| Female | 12 | 2012 | 50063 | 0.050 |
Why?
|
| Arachidonic Acid | 2 | 2012 | 65 | 0.050 |
Why?
|
| Enzyme Inhibitors | 4 | 2010 | 657 | 0.050 |
Why?
|
| Freezing | 1 | 2001 | 32 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2006 | 394 | 0.040 |
Why?
|
| Airway Resistance | 3 | 1995 | 71 | 0.040 |
Why?
|
| Receptors, Bradykinin | 1 | 2000 | 12 | 0.040 |
Why?
|
| Fura-2 | 1 | 2000 | 22 | 0.040 |
Why?
|
| Diamines | 1 | 2000 | 11 | 0.040 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2000 | 12 | 0.040 |
Why?
|
| Macrocyclic Compounds | 1 | 2000 | 8 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2003 | 623 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2000 | 17 | 0.040 |
Why?
|
| Muscarinic Antagonists | 1 | 2000 | 61 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 125 | 0.040 |
Why?
|
| Calcium Channels | 1 | 2000 | 183 | 0.040 |
Why?
|
| Piperidines | 1 | 2000 | 171 | 0.040 |
Why?
|
| Muscle Development | 4 | 1992 | 45 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 3490 | 0.040 |
Why?
|
| Potassium | 3 | 1987 | 271 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2014 | 3586 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2000 | 262 | 0.040 |
Why?
|
| Phenotype | 2 | 2008 | 2579 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2014 | 2163 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 1998 | 15 | 0.040 |
Why?
|
| Tidal Volume | 2 | 2010 | 61 | 0.030 |
Why?
|
| Immunoglobulin E | 2 | 1997 | 152 | 0.030 |
Why?
|
| Polyamines | 1 | 1998 | 38 | 0.030 |
Why?
|
| Norepinephrine | 2 | 1989 | 174 | 0.030 |
Why?
|
| Ribonucleases | 1 | 1998 | 97 | 0.030 |
Why?
|
| Pulmonary Stretch Receptors | 1 | 1997 | 3 | 0.030 |
Why?
|
| Receptors, Prostaglandin E, EP1 Subtype | 1 | 1997 | 3 | 0.030 |
Why?
|
| Mast Cells | 1 | 1998 | 97 | 0.030 |
Why?
|
| Iloprost | 1 | 1997 | 15 | 0.030 |
Why?
|
| Humans | 11 | 2009 | 96127 | 0.030 |
Why?
|
| Xanthenes | 1 | 1997 | 23 | 0.030 |
Why?
|
| Intradermal Tests | 1 | 1997 | 3 | 0.030 |
Why?
|
| Eosinophils | 1 | 1998 | 199 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 1997 | 62 | 0.030 |
Why?
|
| Carbon Dioxide | 2 | 1977 | 212 | 0.030 |
Why?
|
| Acidosis, Respiratory | 1 | 1977 | 8 | 0.030 |
Why?
|
| Cattle | 2 | 1998 | 387 | 0.030 |
Why?
|
| Allergens | 1 | 1997 | 191 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 126 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2012 | 40 | 0.030 |
Why?
|
| Tromethamine | 1 | 1995 | 4 | 0.030 |
Why?
|
| Time Factors | 4 | 1994 | 5585 | 0.030 |
Why?
|
| Extracellular Space | 2 | 1991 | 90 | 0.030 |
Why?
|
| Cyproheptadine | 1 | 1995 | 10 | 0.030 |
Why?
|
| Cat Diseases | 1 | 1995 | 20 | 0.030 |
Why?
|
| Drug Interactions | 2 | 1993 | 245 | 0.030 |
Why?
|
| Peptides | 1 | 1998 | 672 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 1995 | 910 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2014 | 16 | 0.030 |
Why?
|
| Tetrodotoxin | 1 | 1994 | 51 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 138 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 1829 | 0.030 |
Why?
|
| Propranolol | 1 | 1994 | 44 | 0.030 |
Why?
|
| Mice | 4 | 2012 | 12562 | 0.030 |
Why?
|
| Pharmaceutical Vehicles | 1 | 1993 | 7 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1993 | 63 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 285 | 0.030 |
Why?
|
| Amides | 2 | 2003 | 56 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 444 | 0.020 |
Why?
|
| Anaphylaxis | 2 | 1991 | 33 | 0.020 |
Why?
|
| Androstadienes | 2 | 2003 | 74 | 0.020 |
Why?
|
| Contractile Proteins | 2 | 1999 | 57 | 0.020 |
Why?
|
| Calcium Signaling | 2 | 2004 | 142 | 0.020 |
Why?
|
| Glucose | 1 | 1995 | 701 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 139 | 0.020 |
Why?
|
| Parasympathomimetics | 1 | 1992 | 8 | 0.020 |
Why?
|
| Antigens | 1 | 1993 | 231 | 0.020 |
Why?
|
| Verapamil | 1 | 1991 | 34 | 0.020 |
Why?
|
| Immunity, Active | 1 | 1991 | 10 | 0.020 |
Why?
|
| Arachidonic Acids | 1 | 1991 | 38 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 1991 | 122 | 0.020 |
Why?
|
| Pyridines | 2 | 2003 | 319 | 0.020 |
Why?
|
| Microcomputers | 1 | 1991 | 26 | 0.020 |
Why?
|
| Endotoxins | 1 | 1990 | 38 | 0.020 |
Why?
|
| Nitroprusside | 2 | 2006 | 32 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 1991 | 368 | 0.020 |
Why?
|
| Butadienes | 1 | 2010 | 34 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1990 | 243 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2010 | 297 | 0.020 |
Why?
|
| Smooth Muscle Myosins | 1 | 2009 | 5 | 0.020 |
Why?
|
| Nitriles | 1 | 2010 | 157 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1989 | 75 | 0.020 |
Why?
|
| Oxygen | 1 | 1994 | 788 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 36 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1990 | 437 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2012 | 710 | 0.020 |
Why?
|
| Bronchial Spasm | 2 | 1986 | 15 | 0.020 |
Why?
|
| Tyramine | 1 | 1988 | 4 | 0.020 |
Why?
|
| Plethysmography | 1 | 2008 | 18 | 0.020 |
Why?
|
| Bronchial Provocation Tests | 1 | 2008 | 25 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2008 | 79 | 0.020 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1988 | 34 | 0.020 |
Why?
|
| Carbachol | 1 | 1987 | 36 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1990 | 627 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 232 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2008 | 202 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2007 | 156 | 0.020 |
Why?
|
| Oxygen Consumption | 2 | 1986 | 257 | 0.020 |
Why?
|
| Cholesterol, Dietary | 1 | 2006 | 27 | 0.020 |
Why?
|
| Receptors, Histamine | 1 | 1986 | 5 | 0.020 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2006 | 13 | 0.020 |
Why?
|
| Cholinergic Fibers | 1 | 2006 | 24 | 0.020 |
Why?
|
| Electrophoresis | 1 | 1986 | 54 | 0.020 |
Why?
|
| Myofibrils | 1 | 1986 | 22 | 0.020 |
Why?
|
| Bronchial Diseases | 1 | 1986 | 13 | 0.010 |
Why?
|
| Pedigree | 1 | 2008 | 982 | 0.010 |
Why?
|
| Sarcomeres | 1 | 1986 | 27 | 0.010 |
Why?
|
| Triglycerides | 1 | 2006 | 236 | 0.010 |
Why?
|
| Calmodulin | 1 | 1986 | 51 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2006 | 153 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 2006 | 136 | 0.010 |
Why?
|
| Rabbits | 1 | 2006 | 639 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 1986 | 156 | 0.010 |
Why?
|
| Aorta | 1 | 2006 | 294 | 0.010 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2004 | 2 | 0.010 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2004 | 7 | 0.010 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2004 | 20 | 0.010 |
Why?
|
| Lipoxygenase Inhibitors | 2 | 1995 | 36 | 0.010 |
Why?
|
| Cholesterol | 1 | 2006 | 370 | 0.010 |
Why?
|
| Elasticity | 1 | 2004 | 104 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 340 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 2059 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 1986 | 506 | 0.010 |
Why?
|
| Tetany | 1 | 2003 | 1 | 0.010 |
Why?
|
| Marine Toxins | 1 | 2003 | 7 | 0.010 |
Why?
|
| Physiology | 1 | 1983 | 18 | 0.010 |
Why?
|
| Muscle Cells | 1 | 2003 | 18 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 80 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2004 | 482 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 2003 | 115 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 453 | 0.010 |
Why?
|
| rho-Associated Kinases | 1 | 2003 | 162 | 0.010 |
Why?
|
| Animals, Newborn | 2 | 1994 | 535 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2002 | 406 | 0.010 |
Why?
|
| Infusion Pumps | 1 | 2001 | 27 | 0.010 |
Why?
|
| Solutions | 1 | 2001 | 86 | 0.010 |
Why?
|
| Actins | 1 | 2004 | 473 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2003 | 396 | 0.010 |
Why?
|
| Apoptosis | 1 | 2007 | 1763 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 1645 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 992 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1999 | 22 | 0.010 |
Why?
|
| Models, Biological | 1 | 1986 | 1815 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1986 | 2551 | 0.010 |
Why?
|
| Polyelectrolytes | 1 | 1998 | 6 | 0.010 |
Why?
|
| Eosinophil Granule Proteins | 1 | 1998 | 20 | 0.010 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1998 | 39 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 1999 | 134 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 1192 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1999 | 288 | 0.010 |
Why?
|
| Mitochondria, Muscle | 1 | 1978 | 27 | 0.010 |
Why?
|
| Cell Communication | 1 | 1999 | 221 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1977 | 509 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1974 | 51 | 0.010 |
Why?
|
| Middle Aged | 1 | 1994 | 28363 | 0.010 |
Why?
|
| Hydroxyurea | 1 | 1995 | 239 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1994 | 89 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1994 | 85 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1999 | 1666 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1991 | 27 | 0.010 |
Why?
|
| Bronchography | 1 | 1991 | 11 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 1267 | 0.010 |
Why?
|
| Histamine H2 Antagonists | 1 | 1991 | 13 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1990 | 36 | 0.010 |
Why?
|
| Vasodilation | 1 | 1990 | 96 | 0.010 |
Why?
|
| Bucladesine | 1 | 1989 | 13 | 0.000 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1989 | 17 | 0.000 |
Why?
|
| Colforsin | 1 | 1989 | 75 | 0.000 |
Why?
|
| Rats | 1 | 1994 | 4154 | 0.000 |
Why?
|
| Age Factors | 1 | 1991 | 1963 | 0.000 |
Why?
|
| Methylhistamines | 1 | 1980 | 1 | 0.000 |
Why?
|
| Pyrilamine | 1 | 1980 | 1 | 0.000 |
Why?
|
| Metiamide | 1 | 1980 | 2 | 0.000 |
Why?
|
| Receptors, Histamine H2 | 1 | 1980 | 5 | 0.000 |
Why?
|
| Rana temporaria | 1 | 1978 | 1 | 0.000 |
Why?
|
| Rana pipiens | 1 | 1978 | 12 | 0.000 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1978 | 10 | 0.000 |
Why?
|
| Anura | 1 | 1978 | 22 | 0.000 |
Why?
|
| Oxidative Phosphorylation | 1 | 1978 | 64 | 0.000 |
Why?
|
| Muscles | 1 | 1978 | 193 | 0.000 |
Why?
|
| Proteins | 1 | 1978 | 816 | 0.000 |
Why?
|